These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21683785)

  • 1. Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a.
    Veneskoski M; Turunen SP; Kummu O; Nissinen A; Rannikko S; Levonen AL; Hörkkö S
    Free Radic Biol Med; 2011 Aug; 51(4):834-43. PubMed ID: 21683785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malondialdehyde-Acetaldehyde Modified (MAA) Proteins Differentially Effect the Inflammatory Response in Macrophage, Endothelial Cells and Animal Models of Cardiovascular Disease.
    Duryee MJ; Clemens DL; Opperman PJ; Thiele GM; Duryee LM; Garvin RP; Anderson DR
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration.
    Tuma DJ; Thiele GM; Xu D; Klassen LW; Sorrell MF
    Hepatology; 1996 Apr; 23(4):872-80. PubMed ID: 8666344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques.
    Wang C; Turunen SP; Kummu O; Veneskoski M; Lehtimäki J; Nissinen AE; Hörkkö S
    Int Immunol; 2013 Oct; 25(10):575-87. PubMed ID: 23900424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts.
    Kummu O; Turunen SP; Prus P; Lehtimäki J; Veneskoski M; Wang C; Hörkkö S
    Immunology; 2014 Mar; 141(3):416-30. PubMed ID: 24168430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malondialdehyde-acetaldehyde haptenated protein binds macrophage scavenger receptor(s) and induces lysosomal damage.
    Willis MS; Klassen LW; Carlson DL; Brouse CF; Thiele GM
    Int Immunopharmacol; 2004 Jul; 4(7):885-99. PubMed ID: 15182728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates.
    Latvala J; Melkko J; Parkkila S; Järvi K; Makkonen K; Niemelä O
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1648-53. PubMed ID: 11707639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.
    Hörkkö S; Bird DA; Miller E; Itabe H; Leitinger N; Subbanagounder G; Berliner JA; Friedman P; Dennis EA; Curtiss LK; Palinski W; Witztum JL
    J Clin Invest; 1999 Jan; 103(1):117-28. PubMed ID: 9884341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay.
    Xu D; Thiele GM; Kearley ML; Haugen MD; Klassen LW; Sorrell MF; Tuma DJ
    Chem Res Toxicol; 1997 Sep; 10(9):978-86. PubMed ID: 9305579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative and malondialdehyde modification of low-density lipoprotein: a comparative study of binding and degradation by macrophages and endothelial cells.
    Zhou M; Chen Y; Liu S; Ding Z; Pang Z; Wan J
    Br J Biomed Sci; 1998 Sep; 55(3):192-8. PubMed ID: 10367404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions.
    Tuominen A; Miller YI; Hansen LF; Kesäniemi YA; Witztum JL; Hörkkö S
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2096-102. PubMed ID: 16794225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.
    Kyrklund M; Kummu O; Kankaanpää J; Akhi R; Nissinen A; Turunen SP; Pussinen P; Wang C; Hörkkö S
    PLoS One; 2018; 13(1):e0191216. PubMed ID: 29329335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation.
    Willis MS; Klassen LW; Tuma DJ; Sorrell MF; Thiele GM
    Alcohol Clin Exp Res; 2002 Jan; 26(1):94-106. PubMed ID: 11821659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
    Holvoet P; Perez G; Zhao Z; Brouwers E; Bernar H; Collen D
    J Clin Invest; 1995 Jun; 95(6):2611-9. PubMed ID: 7769103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of IgG monoclonal antibodies specific for malondialdehyde.
    Choi JW; Kim DJ; Rhim JH; Chung JH; Chung HK
    Hybrid Hybridomics; 2003 Aug; 22(4):259-62. PubMed ID: 14511571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.
    Gonen A; Hansen LF; Turner WW; Montano EN; Que X; Rafia A; Chou MY; Wiesner P; Tsiantoulas D; Corr M; VanNieuwenhze MS; Tsimikas S; Binder CJ; Witztum JL; Hartvigsen K
    J Lipid Res; 2014 Oct; 55(10):2137-55. PubMed ID: 25143462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease.
    Rolla R; Vay D; Mottaran E; Parodi M; Traverso N; Aricó S; Sartori M; Bellomo G; Klassen LW; Thiele GM; Tuma DJ; Albano E
    Hepatology; 2000 Apr; 31(4):878-84. PubMed ID: 10733543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity.
    Schwarz M; Spath L; Lux CA; Paprotka K; Torzewski M; Dersch K; Koch-Brandt C; Husmann M; Bhakdi S
    Thromb Haemost; 2008 Jul; 100(1):110-8. PubMed ID: 18612545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.